Low-dose rate telecobalt therapy as a boost against esophageal carcinomas. 1992

S Yamada, and Y Takai, and K Nemoto, and Y Ogawa, and Y Kakuto, and A Hoshi, and K Sakamoto
Department of Radiology, Tohoku University School of Medicine, Sendai, Japan.

The results of treating 54 esophageal carcinomas with low-dose rate telecobalt therapy (LDRT) as a boost were compared with those of treating 97 esophageal carcinomas with conventionally fractionated irradiation alone (CFI). The LDRT (100 cGy/hr, 500 to 700 cGy/day, a total dose of 1400 to 2000 cGy) was boosted at 10 days after 6000 cGy of the CFI dose. Although the LDRT group included more advanced cases than the CFI group, local effects and survival rates in the former group were slightly better than in the latter group. Late complications were more severe in the LDRT group. However, they were acceptable when the total dose administered to this group was less than 8000 cGy. Using LDRT as a boost against esophageal carcinomas was found to be satisfactory therapeutically.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D011867 Radioisotope Teletherapy A type of high-energy radiotherapy using a beam of gamma-radiation produced by a radioisotope source encapsulated within a teletherapy unit. Teleradioisotope Therapy,Teletherapy, Radioisotope,Therapy, Teleradioisotope
D011879 Radiotherapy Dosage The total amount of radiation absorbed by tissues as a result of radiotherapy. Dosage, Radiotherapy,Dosages, Radiotherapy,Radiotherapy Dosages
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D002277 Carcinoma A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for "cancer." Carcinoma, Anaplastic,Carcinoma, Spindle-Cell,Carcinoma, Undifferentiated,Carcinomatosis,Epithelial Neoplasms, Malignant,Epithelioma,Epithelial Tumors, Malignant,Malignant Epithelial Neoplasms,Neoplasms, Malignant Epithelial,Anaplastic Carcinoma,Anaplastic Carcinomas,Carcinoma, Spindle Cell,Carcinomas,Carcinomatoses,Epithelial Neoplasm, Malignant,Epithelial Tumor, Malignant,Epitheliomas,Malignant Epithelial Neoplasm,Malignant Epithelial Tumor,Malignant Epithelial Tumors,Neoplasm, Malignant Epithelial,Spindle-Cell Carcinoma,Spindle-Cell Carcinomas,Tumor, Malignant Epithelial,Undifferentiated Carcinoma,Undifferentiated Carcinomas
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D002423 Cause of Death Factors which produce cessation of all vital bodily functions. They can be analyzed from an epidemiologic viewpoint. Causes of Death,Death Cause,Death Causes

Related Publications

S Yamada, and Y Takai, and K Nemoto, and Y Ogawa, and Y Kakuto, and A Hoshi, and K Sakamoto
February 1986, Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica,
S Yamada, and Y Takai, and K Nemoto, and Y Ogawa, and Y Kakuto, and A Hoshi, and K Sakamoto
November 1974, Journal de radiologie, d'electrologie, et de medecine nucleaire,
S Yamada, and Y Takai, and K Nemoto, and Y Ogawa, and Y Kakuto, and A Hoshi, and K Sakamoto
January 1994, Urologia internationalis,
S Yamada, and Y Takai, and K Nemoto, and Y Ogawa, and Y Kakuto, and A Hoshi, and K Sakamoto
June 1969, Rinsho hoshasen. Clinical radiography,
S Yamada, and Y Takai, and K Nemoto, and Y Ogawa, and Y Kakuto, and A Hoshi, and K Sakamoto
January 1966, Rinsho hoshasen. Clinical radiography,
S Yamada, and Y Takai, and K Nemoto, and Y Ogawa, and Y Kakuto, and A Hoshi, and K Sakamoto
January 2013, Brachytherapy,
S Yamada, and Y Takai, and K Nemoto, and Y Ogawa, and Y Kakuto, and A Hoshi, and K Sakamoto
January 2012, Brachytherapy,
S Yamada, and Y Takai, and K Nemoto, and Y Ogawa, and Y Kakuto, and A Hoshi, and K Sakamoto
January 1958, Minerva fisioterapica e radiobiologica,
S Yamada, and Y Takai, and K Nemoto, and Y Ogawa, and Y Kakuto, and A Hoshi, and K Sakamoto
January 2019, Brachytherapy,
S Yamada, and Y Takai, and K Nemoto, and Y Ogawa, and Y Kakuto, and A Hoshi, and K Sakamoto
September 1999, International journal of radiation oncology, biology, physics,
Copied contents to your clipboard!